Tert-butyl 4-[5-amino-6-[2-(4-morpholin-4-yl-3-pyridinyl)acetyl]pyrazin-2-yl]piperazine-1-carboxylate
C24H33N7O4 — CID 167538107
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 4-[5-amino-6-[2-(4-morpholin-4-yl-3-pyridinyl)acetyl]pyrazin-2-yl]piperazine-1-carboxylate
Tert-butyl 4-[5-amino-6-[2-(4-morpholin-4-yl-3-pyridinyl)acetyl]pyrazin-2-yl]piperazine-1-carboxylate (PubChem CID 167538107) has the molecular formula C24H33N7O4 and a molecular weight of 483.57 g/mol. Its IUPAC name is tert-butyl 4-[5-amino-6-[2-(4-morpholin-4-yl-3-pyridinyl)acetyl]pyrazin-2-yl]piperazine-1-carboxylate.
Molecular Properties
| Compound Name | Tert-butyl 4-[5-amino-6-[2-(4-morpholin-4-yl-3-pyridinyl)acetyl]pyrazin-2-yl]piperazine-1-carboxylate |
|---|---|
| PubChem CID | 167538107 |
| Molecular Formula | C24H33N7O4 |
| Molecular Weight | 483.57 g/mol |
| Exact Mass | 483.26 |
| IUPAC Name | tert-butyl 4-[5-amino-6-[2-(4-morpholin-4-yl-3-pyridinyl)acetyl]pyrazin-2-yl]piperazine-1-carboxylate |
| SMILES | CC(C)(C)OC(=O)N1CCN(c2cnc(N)c(C(=O)Cc3cnccc3N3CCOCC3)n2)CC1 |
| InChI | InChI=1S/C24H33N7O4/c1-24(2,3)35-23(33)31-8-6-30(7-9-31)20-16-27-22(25)21(28-20)19(32)14-17-15-26-5-4-18(17)29-10-12-34-13-11-29/h4-5,15-16H,6-14H2,1-3H3,(H2,25,27) |
| InChIKey | XTHHHFCOHCXTCK-UHFFFAOYSA-N |
| XLogP | 1.77 |
| TPSA | 127.01 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 483.57 |
| LogP ≤ 5 | 1.77 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 167538107 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.